Enhancing post – operative treatment for pancreatic ductal adenocarcinoma through AI

Nelson Dusetti posted on X:

“We are very grateful to Davide Melisi for the thoughtful editorial and to Annals of Oncology for featuring our work.

Circumventing human limits in precision oncology: AI-enhanced tailoring of post-operative treatment for pancreatic ductal adenocarcinoma.”

Source: Nelson Dusetti/X

Circumventing human limits in precision oncology: AI-enhanced tailoring of post-operative treatment for pancreatic ductal adenocarcinoma.

Authors: S. Casalino, C. Zecchetto, V. Merz, A. Quinzii, S. Pietrobono, and D. Melisi.

Nelson Dusetti is the Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM. He is also research director at INSERM. He is the Head of the Department of Translational Research and Innovative Therapies at CRCM.